Laparoscopic Surgery for Pediatric Malignant Ovarian Germ Cell Tumors After Neoadjuvant Chemotherapy: A Single-Center Retrospective Study
Journal of Clinical Medicine · 09.07.2026 · 15 (14) · 5366
DOI: 10.3390/jcm15145366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.07.2026. Verfasst von Jiabin Cai und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology Surgery, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Pioneer" and "Leading Goose" R&D Program of Zhejiang Province, Medical Science and Technology Project of Zhejiang Province, “Pioneer” and “Leading Goose” R&D Program of Zhejiang Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
The purpose of this study was to evaluate the clinical effects and safety for cancer treatment of neoadjuvant chemotherapy (NACT) when combined with laparoscopic fertility-sparing (anatomical preservation) surgery in pediatric patients who have large malignant ovarian germ cell tumors (MOGCTs).
Methods
We performed a retrospective analysis on seven young female patients with a median age of 8.8 years (range: 10 months to 13.4 years). The patients were treated between 2015 and 2023, and all of them received two to three cycles of JEB (carboplatin, etoposide, and bleomycin) regimen as NACT. After the NACT, these patients had laparoscopic (n = 7) unilateral salpingo-oophorectomy.
Results
Neoadjuvant chemotherapy (NACT) achieved a median reduction in tumor volume of 91% (range: 85% to 97%). All the procedures were completed successfully and there was no need to convert to open surgery. The median operative time was 85 min (range: 70 to 120 min), and the blood loss was minimal. The median blood loss was 10 mL, with a range of 5 to 50 mL. In patients with yolk sac tumors, alpha-fetoprotein (AFP) levels returned to normal within a median of 20 days after the operation. With a median follow-up of 54 months (range: 18 to 118 months), all the patients had 100% disease-free survival.
Conclusions
This study suggests that NACT combined with laparoscopic fertility-sparing (anatomical preservation) surgery may be effective and appears promising for selected pediatric patients with MOGCTs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology Surgery, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.
- Department of Oncology Surgery, Children's Hospital, National Clinical Research Center for Children and Adolescents' Health and Diseases, Zhejiang University School of Medicine, Hangzhou 310052, China.
ORCID-Profile: Jieni Xiong, Xuan Wu, Lifeng Zhang, Jinhu Wang
Förderung
- "Pioneer" and "Leading Goose" R&D Program of Zhejiang Province
- Medical Science and Technology Project of Zhejiang Province
- “Pioneer” and “Leading Goose” R&D Program of Zhejiang Province
Zitieren
APA
Cai, J., Xiong, J., Wu, X., He, M., Zhang, L., Lu, D., Mao, J., Li, L., Tang, Y., Ding, Z., Liu, M., Hou, L., Wang, Y., Wang, Q., Meng, J., Chen, M., & Wang, J. (2026). Laparoscopic Surgery for Pediatric Malignant Ovarian Germ Cell Tumors After Neoadjuvant Chemotherapy: A Single-Center Retrospective Study. Journal of Clinical Medicine, 15(14), 5366. https://doi.org/10.3390/jcm15145366
Vancouver
Cai J, Xiong J, Wu X, He M, Zhang L, Lu D, et al. Laparoscopic Surgery for Pediatric Malignant Ovarian Germ Cell Tumors After Neoadjuvant Chemotherapy: A Single-Center Retrospective Study. Journal of Clinical Medicine. 2026;15(14):5366. doi:10.3390/jcm15145366
BibTeX
@article{Cai2026,
author = {Cai, Jiabin and Xiong, Jieni and Wu, Xuan and He, Min and Zhang, Lifeng and Lu, Dongfang and Mao, Junqing and Li, Linjie and Tang, Yinbing and Ding, Zheyu and Liu, Ming and Hou, Li and Wang, Yuwei and Wang, Qi and Meng, Jinwen and Chen, Ming and Wang, Jinhu},
title = {Laparoscopic Surgery for Pediatric Malignant Ovarian Germ Cell Tumors After Neoadjuvant Chemotherapy: A Single-Center Retrospective Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {14},
pages = {5366},
doi = {10.3390/jcm15145366}
}
EUVIMED